Modern aproaches to diabetic macular edema diagnosticks

Diabetic macular edema (DME) continues to be an important problem of modern ophthalmology and endocrinology. The risk of edema is higher in patients with type 2 diabetes. Thus, this is the main cause of irreversible vision loss in these patients. DME is one of the prognostically unfavorable and difficult to treat manifestations of diabetic retinopathy. As the main cause of vision loss in diabetic patients, diabetic macular edema is often not diagnosed immediately, which causes difficulties in the treatment of pathology. Thus, early diagnosis and timely treatment of this disease is the key to successfully counteract the uncontrolled decline in the patient’s visual functions.

In this article, the team of authors highlighted the possibilities of informative instrumental research methods available in the Arsenal of modern ophthalmological services. Based on the analysis of modern literature, the main principles of these diagnostic methods were indicated, their key capabilities and limitations compared to each other were highlighted. Knowledge of these characteristics is, in our opinion, an integral and most important tool in the Arsenal of a practicing ophthalmologist who supervises patients with this pathology.

diabetes mellitus, diabetic macular edema, diabetic retinopathy, optical coherence tomography, angiography

1. Трахтенберг Ю.А., Аметов А.С., Демидова Т.Ю., Воробьева И.В. Антиоксидантная терапия непролиферативной диабетической ретинопатии // Врач. — 2006. — №11. — С. 36–39. [Trakhtenberg YuA, Ametov AS, Demidova TYu, Vorob’eva IV. Antioksidantnaya terapiya neproliferativnoy diabeticheskoy retinopatii. Vrach. 2006;(11):36-39. (In Russ.)]

2. White NH, Sun W, Cleary PA, et al. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes. 2010;59(5):1244-1253. doi: https://doi.org/10.2337/db09-1216

3. Bhagat N, Grigorian R, Tutela A, Zarbin M. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54(1):1-32. doi: https://doi.org/10.1016/j.survophthal.2008.10.001

4. Балашевич Л.И. Глазные проявления диабета. — СПб.: МАПО, 2004. — 382 с. [Balashevich LI. Glaznye proyavleniya diabeta. Saint Petersburg: Medical Academy of Post-Graduate Education; 2004. 382 p. (In Russ.)]

5. Балашевич Л.И., Измайлов А.С. Диабетическая офтальмопатия. — СПб.: Человек, 2012. — 336 с. [Balashevich LI, Izmaylov AS. Diabeticheskaya oftal’mopatiya. Saint Petersburg: Chelovek; 2012. 336 p. (In Russ.)]

6. Haller JA, Schachat AP. Update on the pathophisiology, molecular biology, and treatment of macular edema. Advanced studies in ophthalmology. 2007;4(7):178-190.

7. Романенко И.А., Черкасова В.В., Егоров Е.А. Диабетический макулярный отек. Классификация, клиника, лечение // РМЖ. Клиническая офтальмология. — 2010. — Т. 11. — №1. — С. 30–32. [Romanenko IA, Cherkasova VV, Egorov EA. Diabetic macular edema. Classification, clinic, treatment. RMZh. Klinicheskaia oftal’mologiia. 2010;11(1):30-32. (In Russ.)]

8. Bernardes R, Dias J, Cunha-Vaz J. Mapping the human blood-retinal barrier function. IEEE Trans Biomed Eng . 2005;52(1):106-116. doi: https://doi.org/10.1109/TBME.2004.839801

9. Gardner TW, Aiello LP. Pathogenesis of diabetic retinopathy. In: Flynn HW, Smiddy WE. Diabetes and ocular disease: past, present and future therapies. Ophthalmology monographs. N-Y; 2000. Р. 49-70.

10. Soheilian M, Ramezani A, Obudi A, et al. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Ophthalmology. 2009;116(6):1142-1150. doi: https://doi.org/10.1016/j.ophtha.2009.01.011

11. Stefánsson E. Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol. 2006;51(4):364-380. doi: https://doi.org/10.1016/j.survophthal.2006.04.005

12. Bhagat N, Grigorian R, Tutela A, Zarbin N. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54(1):1-32. doi: https://doi.org/10.1016/j.survophthal.2008.10.001

13. Vujosevic S, Casciano M, Pilotto E, et al. Diabetic macular edema: fundus autofluorescence and functional correlations. Invest Ophthalmol Vis Sci. 2011; 52(1):442-448. doi: https://doi.org/10.1167/iovs.10-5588

14. Vujosevic S, Pilotto E, Bottega E, et al. Retinal fixation impairment in diabetic macular edema. Retina. 2008;28(10):1443-1450. doi: https://doi.org/10.1097/IAE.0b013e318183571e

15. Wirostko B, Wong TY, Simo R. Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res. 2008;27(6):608-621. doi: https://doi.org/10.1016/j.preteyeres.2008.09.002

16. Virgili G, Menchini F, Murro V, et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2011;6(7):CD008081. doi: https://doi.org/10.1002/14651858.CD008081.pub2

17. Luo X, Frishman LJ. Retinal Pathway Origins of the Pattern Electroretinogram (PERG). Invest Ophthalmol Vis Sci. 2011;52(12):8571-8584. doi: https://doi.org/10.1167/iovs.11-8376

18. Park HY, Kim IT, Park CK. Early diabetic changes in the nerve fibre layer at the macula detected by spectral domain optical coherence tomography. Br J Ophthalmol. 2011;95(9):1223-1228. doi: https://doi.org/10.1136/bjo.2010.191841

19. Peng PH, Lin HS, Lin S. Nerve fibre layer thinning in patients with preclinical retinopathy. Can J Ophthalmol. 2009;44(4):417-422. doi: https://doi.org/10.3129/i09-112

20. Sakata K, Funatsu H, Harino S, et al. Relationship of macular microcirculation and retinal thickness with visual acuity in diabetic macular edema. Ophthalmology. 2007;114(11):2061-2069. doi: https://doi.org/10.1016/j.ophtha.2007.01.003

21. Бикбов М.М., Файзрахманов Р.Р., Зайнуллин Р.М., и др. Макулярный отек как проявление диабетической ретинопатии // Сахарный диабет. — 2017. — Т. 20. — №4. — С. 263–269. [Bikbov MM, Fayzrakhmanov RR, Zaynullin RM. Macular oedema as manifestation of diabetic retinopathy. Diabetes Mellitus. 2017;20(4):263–269. (In Russ.)]. doi: https://doi.org/10.14341/DM8328

22. Kylstra JA, Brown JC, Jaffe GJ, et al. The importance of fluorescein angiography in planning laser treatment of diabetic macular edema. Ophthalmology. 1999;106(11):2068-2073. doi: https://doi.org/10.1016/S0161-6420(99)90485-2

23. Bresnick GH. Diabetic macular edema: A review. Ophthalmology. 1986;93:989-997. doi: https://doi.org/10.1016/s0161-6420(86)33650-9

24. Carpineto P, Mastropasqua R, Marchini G, et al. Reproducibility and repeatability of foveal avascular zone measurements in healthy subjects by optical coherence tomography angiography. Br J Ophthalmol. 2016;100(5):671-676. doi: https://doi.org/10.1136/bjophthalmol-2015-307330

25. Hwang TS, Jia Y, Gao SS, et al. Optical coherence tomography angiography features of diabetic retinopathy. Retina. 2015;35(11):2371-2376. doi: https://doi.org/10.1097/IAE.0000000000000716

26. Hwang TS, Gao SS, Liu L, et al. Automated quantification of capillary nonperfusion using optical coherence tomography angiography in diabetic retinopathy. JAMA Ophthalmol. 2016;134(4):367-373. doi: https://doi.org/10.1001/jamaophthalmol.2015.5658

27. Shahlaee A, Pefkianaki M, Hsu J, Ho AC. Measurement of foveal avascular zone dimensions and its reliability in healthy eyes using optical coherence tomography angiography. Am J Ophthalmol. 2016;161:50-55.e51. doi: https://doi.org/10.1016/j.ajo.2015.09.026

28. Takase N, Nozaki M, Kato A, et al. Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography. Retina. 2015;35(11):2377-2383. doi: https://doi.org/10.1097/IAE.0000000000000849

29. Bradley PD, Sim DA, Keane PA, et al. The evaluation of diabetic macular ischemia using optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57(2):626-631. doi: https://doi.org/10.1167/iovs.15-18034

30. Couturier A, Mane V, Bonnin S, et al. Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography. Retina. 2015;35(11):2384-2391. doi: https://doi.org/10.1097/IAE.0000000000000859

31. Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, et al. Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2017;237(4):185-122. doi: https://doi.org/10.1159/000458539

32. Kozak I, El-Emam SY, Cheng L, et al. Fluorescein angiography versus optical coherence tomography-guided planning for macular laser photocoagulation in diabetic macular edema. Retina. 2014;34(8):1600-1605. doi: https://doi.org/10.1097/IAE.0000000000000120

33. Schmidt-Erfurth U, Chong V, Loewenstein A, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014;98(9):1144-1167. doi: https://doi.org/10.1136/bjophthalmol-2014-305702

34. Gerendas B, Simader C, Deak GG, et al. Morphological parameters relevant for visual and anatomic outcomes during anti-VEGF therapy of diabetic macular edema in the RESTORE trial. Invest Ophthalmol Vis Sci. 2014;55:1791-1791.

35. Bolz M, Kriechbaum K, Simader C, et al. In vivo retinal morphology after grid laser treatment in diabetic macular edema. Ophthalmology. 2010;117(3):538-544. doi: https://doi.org/10.1016/j.ophtha.2009.07.035

36. Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789–801. doi: https://doi.org/10.1016/j.ophtha.2011.12.039

37. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The restore study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615-625. doi: https://doi.org/10.1016/j.ophtha.2011.01.031

38. Lang GE, Berta A, Eldem BM, et al. Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study. Ophthalmology. 2013;120(10):2004-2012. doi: https://doi.org/10.1016/j.ophtha.2013.02.019

39. Schmidt-Erfurth U, Lang GE, Holz FG, et al. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology. 2014; 121(5):1045-1053. doi: https://doi.org/10.1016/j.ophtha.2013.11.041

40. Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064-1077.e1035. doi: https://doi.org/10.1016/j.ophtha.2010.02.031

41. Korobelnik JF, Do DV, Schmidt-Erfurth U, et al.Intravitreal aflibercept for diabetic macular edema. Ophthalmology. 2014;121(11):2247–2254. doi: https://doi.org/10.1016/j.ophtha.2014.05.006

42. Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193-1203. doi: https://doi.org/10.1056/NEJMoa1414264

43. Prunte C, Fajnkuchen F, Mahmood S, et al. Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study. Br J Ophthalmol. 2016;100(6):787-795. doi: https://doi.org/10.1136/bjophthalmol-2015-307249

44. Pecen PE, Smith AG, Ehlers JP Optical Coherence Tomography Angiography of Acute Macular Neuroretinopathy/Paracentral Acute Middle Maculopathy. JAMA Ophthalmol. 2015 Dec; 133(12): 1478–1480. doi: 10.1001/jamaophthalmol.2015.4100

45. Sun JK, Lin MM, Lammer J, et al. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol. 2014;132(11):1309-1316. doi: https://doi.org/10.1001/jamaophthalmol.2014.2350

46. Shin HJ, Lee SH, Chung H, Kim HC. Association between photoreceptor integrity and visual outcome in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2012;250(1):61-70. doi: https://doi.org/10.1007/s00417-011-1774-x

47. Bolz M, Schmidt-Erfurth U, Deak G, et al. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology. 2009;116(5):914-920. doi: https://doi.org/10.1016/j.ophtha.2008.12.039

48. Gerendas BS, Waldstein SM, Simader C, et al. Three-dimensional automated choroidal volume assessment on standard spectral-domain optical coherence tomography and correlation with the level of diabetic macular edema. Am J Ophthalmol. 2014;158(5):1039-1048. doi: https://doi.org/10.1016/j.ajo.2014.08.001

49. Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol. 1985;103(12):1796-1806

50. Kashani AH, Chen C-L, Gahm JK, et al. Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications.Prog Retin Eye Res. 2017;60:66-100. doi: https://doi.org/10.1016/j.preteyeres.2017.07.002

51. Chen CL, Gahm JK, Zheng F, Optical Coherence Tomography Angiography: A Comprehensive Review of Current Methods and Clinical Applications.

52. Ishibazawa A, Nagaoka T, Takahashi A, et al. Optical Coherence Tomography Angiography in a diabetic retinopathy: A prospective study. Am J Ophthalmol. 2015;160(1):35-44.e1. doi: https://doi.org/10.1016/j.ajo.2015.04.021

53. Chen CL, Wang RK. Optical coherence tomography based angiography [Invited]. Biomed Opt Express. 2017;8(2):1056-1082. doi: https://doi.org/10.1364/BOE.8.001056

54. Campbell JP, Zhang M, Hwang TS, et al. Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography. Sci Rep. 2017;7:42201. doi: https://doi.org/10.1038/srep42201

55. Chalam KV, Sambhav K. Optical coherence tomography angiography in retinal diseases. J Ophthalmic Vis Res. 2016;11(1):84-92. doi: https://doi.org/10.4103/2008-322X.180709

56. Thorell M, Zhang Q, Huang Y, et al. «Swept-source OCT angiography of macular telangiectasia type 2. Ophthalmic Surg Lasers Imaging Retina. 2014;45(5):369-380. doi: https://doi.org/10.3928/23258160-20140909-06

57. Spaide RF, Klancnik JM Jr, Cooney MJ, et al. Volume-rendering optical coherence tomography angiography of macular telangiectasia type 2. Ophthalmology. 2015;122(11):2261-2269. doi: https://doi.org/10.1016/j.ophtha.2015.07.025

58. Nemiroff М, Kuehlewein, Rahimy E, et al. Assessing deep retinal capillary ischemia in paracentral acute middle maculopathy by optical coherence tomography angiography. Am J Ophtalmol. 2016;162:121-132. doi: https://doi.org/10.1016/j.ajo.2015.10.026

59. Moysidis SN, Koulisis N, Ameri H, et al. Multimodal imaging of geographic areas of retinal darkening. Retin Cases Brief Rep. 2015;9(4):347-351. doi: https://doi.org/10.1097/ICB.0000000000000231